Cargando…
Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria
BACKGROUND: Although previous studies showed an increasing prevalence of infections due to multi-drug resistant (MDR) bacteria in the community, specific data on sepsis are lacking. We aimed to assess prevalence, risk factors and outcomes of patients with sepsis due to MDR bacteria. METHODS: An obse...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610920/ https://www.ncbi.nlm.nih.gov/pubmed/31312449 http://dx.doi.org/10.1186/s40248-019-0185-4 |
_version_ | 1783432590693236736 |
---|---|
author | Capsoni, Nicolò Bellone, Pietro Aliberti, Stefano Sotgiu, Giovanni Pavanello, Donatella Visintin, Benedetto Callisto, Elena Saderi, Laura Soldini, Davide Lardera, Luca Monzani, Valter Brambilla, Anna Maria |
author_facet | Capsoni, Nicolò Bellone, Pietro Aliberti, Stefano Sotgiu, Giovanni Pavanello, Donatella Visintin, Benedetto Callisto, Elena Saderi, Laura Soldini, Davide Lardera, Luca Monzani, Valter Brambilla, Anna Maria |
author_sort | Capsoni, Nicolò |
collection | PubMed |
description | BACKGROUND: Although previous studies showed an increasing prevalence of infections due to multi-drug resistant (MDR) bacteria in the community, specific data on sepsis are lacking. We aimed to assess prevalence, risk factors and outcomes of patients with sepsis due to MDR bacteria. METHODS: An observational, retrospective study was conducted on consecutive adult patients coming from the community and admitted to the Policlinico Hospital, Milan, Italy, with a diagnosis of sepsis between January 2011 and December 2015. Primary study outcome was in-hospital mortality. RESULTS: Among 518 patients, at least one MDR bacteria was isolated in 88 (17%). ESBL+ Enterobacteriaceae were the most prevalent MDR bacteria (9.7%) followed by MRSA (3.9%). Independent risk factors for sepsis due to MDR bacteria were septic shock (OR: 2.2; p = 0.002) and hospitalization in the previous 90 days (OR: 2.3; p = 0.003). Independent risk factors for sepsis due to ESBL+ bacteria were hospitalization in the previous 90 days (OR: 2.1; p = 0.02) and stroke (OR: 2.1; p = 0.04). A significantly higher mortality was detected among patients with vs. without MDR bacteria (40.2% vs. 23.1% respectively, p = 0.001). Independent risk factors for mortality among patients with sepsis were coagulation dysfunction (OR: 3.2; p = 0.03), septic shock (OR: 3.2; p = 0.003), and isolation of a MDR bacteria (OR: 4.6; p < 0.001). CONCLUSION: In light of the prevalence and impact of MDR bacteria causing sepsis in patients coming from the community, physicians should consider ESBL coverage when starting an empiric antibiotic therapy in patients with specific risk factors, especially in the presence of septic shock. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40248-019-0185-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6610920 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66109202019-07-16 Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria Capsoni, Nicolò Bellone, Pietro Aliberti, Stefano Sotgiu, Giovanni Pavanello, Donatella Visintin, Benedetto Callisto, Elena Saderi, Laura Soldini, Davide Lardera, Luca Monzani, Valter Brambilla, Anna Maria Multidiscip Respir Med Original Research Article BACKGROUND: Although previous studies showed an increasing prevalence of infections due to multi-drug resistant (MDR) bacteria in the community, specific data on sepsis are lacking. We aimed to assess prevalence, risk factors and outcomes of patients with sepsis due to MDR bacteria. METHODS: An observational, retrospective study was conducted on consecutive adult patients coming from the community and admitted to the Policlinico Hospital, Milan, Italy, with a diagnosis of sepsis between January 2011 and December 2015. Primary study outcome was in-hospital mortality. RESULTS: Among 518 patients, at least one MDR bacteria was isolated in 88 (17%). ESBL+ Enterobacteriaceae were the most prevalent MDR bacteria (9.7%) followed by MRSA (3.9%). Independent risk factors for sepsis due to MDR bacteria were septic shock (OR: 2.2; p = 0.002) and hospitalization in the previous 90 days (OR: 2.3; p = 0.003). Independent risk factors for sepsis due to ESBL+ bacteria were hospitalization in the previous 90 days (OR: 2.1; p = 0.02) and stroke (OR: 2.1; p = 0.04). A significantly higher mortality was detected among patients with vs. without MDR bacteria (40.2% vs. 23.1% respectively, p = 0.001). Independent risk factors for mortality among patients with sepsis were coagulation dysfunction (OR: 3.2; p = 0.03), septic shock (OR: 3.2; p = 0.003), and isolation of a MDR bacteria (OR: 4.6; p < 0.001). CONCLUSION: In light of the prevalence and impact of MDR bacteria causing sepsis in patients coming from the community, physicians should consider ESBL coverage when starting an empiric antibiotic therapy in patients with specific risk factors, especially in the presence of septic shock. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40248-019-0185-4) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-05 /pmc/articles/PMC6610920/ /pubmed/31312449 http://dx.doi.org/10.1186/s40248-019-0185-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Research Article Capsoni, Nicolò Bellone, Pietro Aliberti, Stefano Sotgiu, Giovanni Pavanello, Donatella Visintin, Benedetto Callisto, Elena Saderi, Laura Soldini, Davide Lardera, Luca Monzani, Valter Brambilla, Anna Maria Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria |
title | Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria |
title_full | Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria |
title_fullStr | Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria |
title_full_unstemmed | Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria |
title_short | Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria |
title_sort | prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610920/ https://www.ncbi.nlm.nih.gov/pubmed/31312449 http://dx.doi.org/10.1186/s40248-019-0185-4 |
work_keys_str_mv | AT capsoninicolo prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria AT bellonepietro prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria AT alibertistefano prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria AT sotgiugiovanni prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria AT pavanellodonatella prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria AT visintinbenedetto prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria AT callistoelena prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria AT saderilaura prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria AT soldinidavide prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria AT larderaluca prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria AT monzanivalter prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria AT brambillaannamaria prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria |